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A B S T R A C T   
Objective: To integrate existing literature on barriers and facilitators to implementing interventions for Medically 
Unexplained Symptoms (MUS) in primary and secondary care. 
Method: Systematic review following PRISMA guidelines. A search of PsychINFO/Pubmed/Web of Science was 
performed to select studies focusing on MUS-interventions and implementation. All included papers were 
checked for quality and bias. A narrative synthesis approach was used to describe the included papers by 
implementation level, ranging from the specific intervention to the broader economic/political context. 
Results: 20 (quantitative/qualitative/mixed design) papers were included, but the quantitative studies especially, 
lacked methodological quality, with possible publication bias as a result. Results showed that the intervention 
needs to be acceptable and in line with daily practice routines. The professional's attitude and skills are important 
for implementation success, as well as for overcoming problems in the professional-patient interaction. If patients 
stick to finding a somatic cause, this hampers implementation. A lack of time is a frequently mentioned barrier at 
the organizational level. Barriers/facilitators at the social context level and at the economic/political level were 
barely reported on in the included papers. 
Conclusion: Results were integrated into an existing implementation model, as an example of how MUS- 
interventions can be successfully implemented in practice.   
1. Introduction 
Medically Unexplained Symptoms (MUS) are persistent physical 
symptoms for which no conclusive organic explanation can be found. 
MUS are present in about 40–50% of all primary care consultations [19] 
and about 50% of all secondary care consultations [30]. These symp-
toms can cause mild to severe limitations in the patient's daily life 
functioning, reflected in e.g. lowered health-related quality of life scores 
[52], and work problems [36]. 
Although there are evidence-based treatments available for MUS 
[13], healthcare professionals find it difficult to implement these in-
terventions in clinical practice. In general, only 14% of new evidence- 
based interventions may eventually become part of routine clinical 
practice [50]. ‘Implementation’ refers to the planned introduction of 
(evidence-based) interventions, with the aim of making these an 
integrated part of clinical practice routines [28]. Implementation of 
interventions is most likely to be successful when they are tailored to the 
healthcare context, by taking into account the specific care setting and 
needs of the patient population when developing implementation stra-
tegies [17]. In fact, choosing successful implementation strategies re-
quires knowledge of barriers and facilitators for each level of healthcare 
[48]. 
In the case of MUS, there may be specific concerns regarding the 
setting of care. In fact, the implementation of MUS-interventions may be 
hampered by the prevailing dualism of somatic and psychological care, 
while MUS are pre-eminently at the interface between these healthcare 
fields. In a systematic study of barriers to the diagnosis of somatoform 
symptoms [27], barriers were found that may also be relevant for the 
implementation of MUS-interventions, such as communication barriers, 
and barriers concerning medical ideology. Barriers and facilitators to 
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implementing MUS-interventions in clinical care, however, have not 
been studied systematically before. 
Research in depression emphasizes the importance of studying bar-
riers for diagnosis and for implementation of interventions separately. A 
study focusing on care for men with a depressive disorder [39] reported 
that barriers to depression diagnosis included holding on to male role 
models, and covering up depressive symptoms with other problematic 
behaviors, such as excessive alcohol consumption. Barriers to imple-
menting depression interventions included the tendency of these men to 
want to solve problems themselves, and their ambivalence towards 
treatment [39]. Other barriers to implementing depression interventions 
included non-compliance to the treatment, professionals not following 
treatment guidelines, and psychosocial problems that prevented the 
patient from engaging in treatment [31]. The latter study also showed 
that professionals identified the patient's resistance to a depression 
diagnosis to be a barrier to the successful implementation of depression 
interventions. Thus, while difficulties in diagnosing depression may well 
affect the implementation success of depression interventions, specific 
barriers need to be considered when implementing a new intervention in 
clinical care [5]. 
Therefore, in the current systematic review, we aim to integrate 
existing literature on barriers and facilitators to implementing in-
terventions for MUS in primary and secondary care. 
2. Methods 
2.1. Study design 
A systematic review was performed to study barriers and facilitators 
to implementing MUS-interventions in primary and secondary care. This 
study was registered in PROSPERO (https://www.crd.york.ac.uk/prosp 
ero/; registration number CRD42018098564), and was conducted using 
the Cochrane collaboration's Covidence tool (www.covidence.org) in 
order to ensure that the study was carried out according to the PRISMA 
guidelines ([23]; www.prisma-statement.org). 
2.2. Search strategy and data sources 
In close collaboration with an information specialist from the Central 
Medical Library of the University Medical Center Groningen, we 
composed a search strategy consisting of search terms related to MUS 
and somatic symptom disorder (SSD; i.e. physical symptoms that cause 
severe functional limitations and are accompanied by disproportional 
emotional expressions, cognitions, and/or behaviors) on the one hand, 
and search terms referring to implementation on the other hand. 
Search terms related to MUS/SSD (e.g. “medically unexplained 
symptoms”, “somatic symptom disorder”) were based on an existing 
search strategy that was previously described in the Dutch multidisci-
plinary guideline for the treatment of MUS and somatoform disorders 
[6]. Search terms related to functional syndromes (e.g. fibromyalgia, 
irritable bowel syndrome, chronic fatigue syndrome) were deleted from 
this search strategy. The search strategy was extended with search terms 
related to SSD [4]. The search string related to implementation was 
constructed using a broad definition of implementation, e.g. including 
health knowledge, health care policy, and health literacy. The search 
terms related to MUS/SSD and implementation were connected by the 
Boolean operator AND. This search strategy was specified and optimized 
for each of the data sources, i.e. PsycINFO, Pubmed and Web of Science. 
The results described in the current paper are based on a search con-
ducted on February 11th, 2018 using our final search string (Supple-
mentary file A). Although the original plan was to also study barriers and 
facilitators to interventions for SSD, we did not find any papers specif-
ically focusing on SSD. Therefore, the results discussed in the current 
paper only apply to MUS. 
2.3. Study selection 
All results from our search were uploaded in Covidence. Two re-
searchers (DH, LB) independently screened all papers on title and ab-
stract using well-defined in- and exclusion criteria; in case of 
disagreement, a third researcher (JR) was consulted. Included were 
papers that 1) referred to MUS (including DSM-IV classifications of 
hypochondria and conversion disorder; [3]); 2) described barriers and/ 
or facilitators to the implementation of one or more MUS-interventions. 
Exclusion criteria were 1) studies about Munchhausen by proxy, body 
dysmorphic disorder, or factitious disorder; 2) non-original studies, i.e. 
systematic/narrative reviews, book chapters; 3) (cost-) effectiveness 
studies; 4) studies in other languages than English and Dutch. No se-
lection was made on study design (e.g., quantitative, qualitative, mixed 
design). 
After selection based on title and abstract, full text versions of the 
papers were retrieved; if these versions were not available at the uni-
versity library, authors of the papers were approached via email to share 
their full-text paper. Full-text screening was independently performed 
by DH and LB, using the previously described in- and exclusion criteria 
and consultation from a third researcher (JR) in case of discrepancies. 
Main reasons for exclusion were registered. 
2.4. Data extraction and synthesis 
Data extraction was independently performed on the selected full- 
text papers by two researchers (DH, LB), and included extraction of 
data on authors, year of publication, study aim(s), study population, 
research method, type of MUS-intervention, implementation barriers 
and/or facilitators, and healthcare setting (primary and/or secondary 
care). After data extraction, results were discussed until consensus was 
reached. 
Barriers and facilitators to the implementation of MUS-interventions 
were consecutively identified, categorized by two researchers (DH, LB) 
using the implementation levels described by Grol and Wensing [18] (i. 
e. intervention, professional, patient, organizational context, social 
context, economic/political context), and described as the main results 
of our systematic analysis, using a narrative synthesis approach. 
2.5. Quality and bias assessment 
Quality- and bias assessment was performed using the five levels of 
evidence as described by the Oxford Centre for Evidence-Based Medicine 
[32], with lower levels meaning higher quality of the scientific study. 
Since we included papers with several study designs, all papers were 
thereafter scored using the relevant sections of the Mixed Methods 
Appraisal Tool (MMAT) [35], a quality assessment tool that can be 
applied to quantitative, qualitative, and mixed-methods studies. Since it 
is discouraged to calculate an overall MMAT score, results of the quality 
assessment are presented for each criterion separately. Both the quality 
and bias assessments were performed independently by two researchers 
(DH, LB); in case of conflicting assessment, this was discussed until 
consensus was reached. 
3. Results 
3.1. Search results 
We retrieved a total of 5786 articles (PsycINFO: 701; Pubmed: 2728; 
Web of Science: 2357). After checking for duplicates (using Covidence, 
Refworks, and manual check of duplicates), 5162 papers were available 
for title and abstract screening (Fig. 1). Based on this screening, 149 
papers were eligible for full-text screening. After full-text screening, 21 
papers met our in- and exclusion criteria. One paper [24] could not be 
assessed using the MMAT tool since it neither had a quantitative or 
qualitative, nor a mixed study design (i.e. only the description of an 
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implementation process) and was therefore removed from the final 
study selection, resulting in a final study selection of 20 papers. This 
final selection of papers included 11 quantitative observational study 
designs, 7 qualitative observational study designs, and 2 mixed-methods 
observational designs. 11 studies were conducted in primary care, 6 
studies were conducted in secondary care, 2 studies were conducted in 
both primary and secondary care, and 1 study was not tied to a specific 
healthcare setting. Most studies described the implementation of a 
general or unspecified psychological intervention (12 studies); 4 studies 
specifically focused on reattribution training, 3 studies focused on 
cognitive behavioural therapy, and 1 study focused on communication 
training. 
3.2. Quality and risk of bias assessment 
The final 20 papers were subjected to quality and risk of bias 
assessment. See Table 1 for a complete overview of the level of the 
quality and risk of bias scores per included study. While selection bias 
due to participant recruitment was minimized in 10/11 quantitative 
studies, appropriate measurements were identified in 7/11 studies, 
groups were comparable in 5/11 studies, and data were sufficiently 
completed in 6/11 studies. Of the 7 qualitative studies, 6 met all four 
quality criteria, while one study sufficiently considered the data 
collection context, but failed to use relevant data sources and data 
analysis processes, and did not consider how findings related to re-
searcher's influence. With regard to the quality criteria for mixed- 
method studies, the relevance of the mixed-method approach, the rele-
vance of the integration of qualitative and quantitative data, and the 
consideration of the associated limitations, 1/2 study met all of these 
criteria while the other one met none of them. 
3.3. Barriers and facilitators to implementing MUS/SSD-interventions in 
primary and secondary care 
Table 2 gives a complete overview of the results about barriers and 
facilitators to the implementation of MUS/SSD-interventions in primary 
and secondary care. Results on barriers and facilitators will be discussed 
in more detail below, grouped per implementation level [18,49]. In 
general, barriers at the professional level were, along with barriers at the 
patient level, most frequently reported, while barriers at the social 
context level, and economic/political level were least often described. In 
general, facilitators were less frequently described than barriers, with 
the exception of facilitators within the organizational context. No fa-
cilitators were described at the social context level, and economic/po-
litical level. Supplementary files B and C show the results by healthcare 
setting (secondary care, primary care) or by study design (quantitative, 
qualitative, mixed). 
3.3.1. Intervention 
Barriers - When developing the intervention, it seems important to 
adopt a collaborative, interdisciplinary approach [10] to ensure that the 
intervention is acceptable for those (e.g. medical and psychological) 
disciplines that are implementing the intervention in clinical practice. It 
gets more difficult to implement the intervention in the long term when 
it is not in line with daily practice routines [7]. 
Facilitators- Implementation of the intervention is easier when the 
intervention provides structure or a ‘road map’ [2,14], and when the 
intervention demonstrates its effectiveness in daily practice [8]. Also, an 
Fig. 1. PRISMA flow diagram.  
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1 Aatti et al. 2016 4 Quantitative + + + +
2 Aiarzaguena 
et al. 
2009 4 Qualitative     + + + +
3 Blankenstein 
et al. 
2002 4 Mixed- 




2016 4 Qualitative     + + + +
5 Calpin et al. 2017 4 Quantitative + − − +
6 Cooper et al. 2017 4 Quantitative + − + −
7 De Schipper 
et al. 
2014 4 Quantitative + − − −
8 Dowrick et al. 2008 4 Mixed- 
design         
+ + +




1998 4 Quantitative + + − −
11 Husain et al. 2011 4 Quantitative + − + +
12 McCrae et al. 2015 4 Qualitative     + + + +
13 Moulin et al. 2015 4 Qualitative     + + + +
14 O'Sullivan 
et al. 
2006 4 Quantitative + + − −
15 Peters et al. 2009 4 Qualitative     + + + +
16 Salmon et al. 2007 4 Qualitative     + + + +
17 Sirri et al. 2017 4 Quantitative + + + +
18 Speckens 
et al. 
1995 4 Quantitative + + + +
19 Van der Feltz- 
Cornelis et al. 
1996 4 Quantitative + + − +
20 Walker et al. 1999 4 Quantitative − + − −
+ = study meets this criterion; − = study does not meet this criterion; Grey box means N/A. 
* For more information on the level of evidence score, please see http://www.cebm.net/2016/05/ocebm-levels-of-evidence. 
** For more information on the MMAT, please see [35]. 
D.J.C. H




Results of the systematic analysis of barriers and facilitators to the implementation of MUS/SSD-interventions in primary and secondary care.   
First author Year of 
publication 



















1. Aatti et al. 2016 To determine: 
1) Level of general 
knowledge of Psychogenic 
Nonepileptic Seizures (PNES) 
of French psychiatrists and 
psychiatric residents; 
2) Their perceptions on 
PNES; 
3) The relationship between 
level of education and 
knowledge of PNES, and 
level of experience of case 












believe that psychiatric 
intervention is 
ineffective for the 
treatment of PNES. (Pr) 
1) Have followed a 
training for PNES. (Pr) 
2. Aiarzaguena 
et al. 
2009 To determine: 
1) GPs' attitudes towards 
patients with MUS; 
2) Their experience, 
expectations and the utility 
of the communication 
techniques that were 
proposed; 
3) The feasibility of 
implementing these 
techniques. 
Qualitative Focus groups General Practitioners 
(n = 26) 




1) Difficulties with 
behavioural change in 
patients with MUS. 
(Pa) 
2) Lack of time during 
consultation. (O) 
3) Lack of attention for 
treating MUS during 
the GP training 
program, leads to a 
lack of skills. (Pr) 
1) Treatment is applicable 
to other patient groups 
with psychosocial 
problems. (I) 
2) GPs participated in 
proper training, resulting 
in a better understanding 
of somatizing patients. 
(Pr) 




2002 To determine: 
1) The feasibility of the 
modified reattribution model 
in general practice; 










(n = 10) 
Primary care Reattribution training 
for long-standing 
somatization, as 
provided by GPs 
1) Treatment 
techniques deviate 
from normal working 
style. (I) 
2) GPs feel 
incompetent to apply 
the treatment. (Pr) 
1) Possibility to take a 
refreshment course and/ 
or intervision meetings. 
(O) 
4. Brownell et al. 2016 To determine: 
1) Clinical practitioners' 
experiences of dealing with 
patients with MUPS within 




(n = 12) 
and 
medical specialists 




Interventions for MUS 
(in general) 
1) The physician's 
tendency to keep 
looking for a medical 
diagnosis. (Pr) 
1) The intervention shows 
in practice that it is able to 
improve the patient's 
quality of life. (I) 
5. Calpin et al. 2017 To determine: 
1) The expectations of 
chronic pain patients and 
their treating physicians for 
what is most important to 
them to achieve during the 
first pain clinic visit; 
2) Which outcomes or 
process indicators from the 
clinic visit would be 
satisfying and dissatisfying to 
both patients and physicians; 
3) To compare any 
Quantitative Questionnaires Chronic pain patients 
(n = 100) and 




Chronic pain treatment 
in a pain clinic 
1) Different 
expectations between 
patients and doctors 
regarding treatment of 
chronic pain. (Pa, Pr) 
N/A 
(continued on next page) 
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Table 2 (continued )  
First author Year of 
publication 



















discordance in the 
expectations of both parties 
as well as satisfying and 
dissatisfying clinic outcomes, 
and any correlations with 
patient characteristics. 
6. Cooper et al. 2017 1) To provide an outline of 
how a brief psychotherapy 
service for MUS has been 
implemented across two 
community based academic 
family medicine clinics; 
2) To describe a service 
evaluation project of the 
psychotherapy service. 
Quantitative Questionnaires Patients with MUS 
(n = 18)  
and 
GPs 
(n = 7) 
Primary care Psychotherapy service 
for MUS 





2) Deliver regular 
teaching workshops. (O) 
3) Belief that the 
psychotherapy service is 
acceptable. (Pa). 
7. De Schipper 
et al. 
2014 To determine: 
1) The current opinions on 
functional neurological 
symptoms (FNS) in the 
Netherlands among those 







psychiatrists (n = 64) 
Secondary 
care 
Treatment for FNS (in 
general) 
N/A 1) The neurologist's belief 
that psychiatric care 
should be part of the 
treatment of FNS. (Pr) 
8. Dowrick et al. 2008 To determine: 
1) The views of participating 
practitioners on patients with 
MUS; 
2) The value of and barriers 
to the implementation of 









(n = 70 for the 
questionnaires; n =
24 for the 
interviews) 
Primary care Reattribution treatment 
for MUS 
1) Lack of supervision 
when using the 
treatment. (O) 
2) Patients sticking to a 
somatic cause for their 
symptoms. (Pa) 
2) Patient's learned 
behavior. (Pa) 
3) Patient's secondary 
gain of MUS. (Pa) 
4) Patient choosing not 
to visit the same GP 
every time / lack of 
continuity. (Pa) 
5) GP's lack of 
communication skills 
in managing patients 
with MUS. (Pr) 
6) GP's (negative) 
emotional state during 
consultation. (Pr) 
7) GP's fear of 
encouraging 
dependency when 
offering this treatment. 
(Pr) 
8) Lack of time to 
concentrate on the 
1) Financial rewards or 
payment. (O) 
2) Treatment offers 
structure. (I) 
(continued on next page) 
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Table 2 (continued )  
First author Year of 
publication 




















9) Referral to 
secondary care during 
treatment. (O) 
10) The medical-legal 
context the GP is 
working in. (E) 
9. Furness et al. 2009 To explore: 
1) Attitudes, perceptions and 
experiences of hospital 
pediatric staff caring for 
children with MUS. 
Qualitative Focus groups and 
in-depth 
interviews 
Staff of the pediatrics 
department, 
including nurses and 
consultants (n = 12) 
Secondary 
care 
Treatment of MUS in 
children 
(in general) 
1) Parents sticking to 
finding a medical 
diagnosis for their 
children's MUS. (Pa) 
2) Lack of time. (O) 
3) Absence of a 
structured protocol for 
treatment of MUS. (O) 
1) Good communication 
and motivation skills. (Pr) 
2) Training of treatment/ 
referral skills. (Pr) 
3) Joint treatment 
approach between 




1998 To assess: 
1) The attitudes of Spanish 
GPs towards the care of 
somatizing patients; 
2) The degree of involvement 
that GPs want to adopt in the 
care of somatizing patients. 
Quantitative Questionnaires GPs 
(n = 70) 
Primary care (Psychological) 
treatment for 
somatizing patients 
1) GPs refusing to give 
psychological support 
to somatizing patients. 
(Pr) 
2) Patients with MUS 
evoke negative 
emotions, such as 
frustration, among 
GPs. (Pr) 
1) GPs and mental health 
professionals have a 
shared responsibility 
regarding the 
management of MUS- 
patients. (O) 
11. Husain et al. 2011 1) To explore GPs' attitudes 
towards MUS in Karachi, 
Pakistan; 
2) To determine whether 
GPS' attitudes towards MUS 
are similar to those of GPs in 
the developed world. 
Quantitative Questionnaire GPs 
(n = 429) 
Primary care (Psychological) 
treatment for patients 
with MUS and 
somatization/ 
somatization disorder 
1) GP's belief that there 
is no effective 




1) GP's belief that 
counseling and providing 
psychological 
interventions for MUS is a 
GP's task. (Pr)  
12. McCrae et al. 2015 To determine: 
1) Feasibility and 
acceptability of cognitive 
behavioural interventions for 
MUS and related training 
interventions from the 
perspectives of project 
leaders and key practitioners, 
focusing on: 
- Interventions and pathways 
- Access and utilization 
- Staff training and 
supervision. 












(Training courses for) 
Cognitive behavioural 
interventions for people 
with long-term medical 
conditions and MUS 
1) Professional's use of 
psychiatric 
terminology. (Pr) 
2) Stigma surrounding 
psychological 
interventions, 
especially for people 
from minority ethnic 
cultures. (S) 




limited confidence and 
skills for providing 
treatment for MUS. 
(Pr) 
N/A 
13. Moulin et al. 2015 To determine: 
1) The experiences with, and 
perceptions of, the 





(n = 10) 
Secondary 
care 
Treatment of MUS in 
adolescents 
(in general) 
1) Stigma surrounding 
visiting a psychiatrist 
for MUS. (S) 
1) Patient's belief that 
psychological treatment 
(continued on next page) 
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Table 2 (continued )  
First author Year of 
publication 



















healthcare of adolescents 
with MUS and their parents. 
and 
their parents (n = 16) 
2) Patients and their 
parents sticking to 
finding a somatic cause 
for their physical 
symptoms. (Pa) 
3) Patient's fear of side 
effects when using 
medication. (Pa) 
can help when coping 
with MUS. (Pa) 
14. O'Sullivan 
et al. 
2006 To determine: 
1) The level of understanding 
of the diagnosis of PNES 
among patients' GPs, their 
opinions of the diagnosis and 
it's management options; 
2) The role they feel the GP 
should play in the overall 
management of PNES. 
Quantitative Questionnaire GPs 
(n = 23) 
Primary care Psychological 
treatments for PNES (in 
general) 
1) GP's belief that 
psychological 
interventions are 
ineffective for the 
treatment of PNES. (Pr) 
2) GPs feel 
uncomfortable 
referring patients with 
PNES to psychological 
treatments. (Pr) 
N/A 
15. Peters et al. 2009 To determine: 
1) Potential barriers to 
reattribution and the 
improvement of clinical 
outcome by analyzing 
patients' experiences of 
consultations; 
2) If barriers are particular to 
the reattribution model or to 
MUS management in general. 
Qualitative Semi structured 
interviews 
Patients with MUS 
(n = 23) 
Primary care Reattribution treatment 
for MUS, as provided by 
the GP 





2) Patient's belief that 
GPs only have a limited 










simplification of the 
symptoms. (Pa) 
6) The GP's 
simplification of the 
patient's needs. (Pr) 
N/A 
16. Salmon et al. 2007 To identify: 
1) How GPs' attitudes to 
patients with MUS might 
inhibit their participation 





(n = 33) 
Primary care Reattribution training 
for MUS, as provided by 
GPs 
1) GP's negative and 
dismissing attitudes to 
patients. (Pr) 
2) GP's devaluation of 
psychological 
treatment skills. (Pr) 
1) GP's empathic attitude 
towards patients with 
MUS. (Pr) 
17. Sirri et al. 2017 To explore: 
1) GPs' clinical experience 
with MUS; 
2) the relationship between 
the main features of GP's 
Quantitative Questionnaire GPs 
(n = 347) 
Primary care Treatment of MUS (in 
general) 
1) GP's lack of 
knowledge about the 
role of psychologists in 
the treatment of MUS. 
(Pr) 
1) Extensive training 
about MUS. (Pr) 
(continued on next page) 
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Table 2 (continued )  
First author Year of 
publication 



















experience and gender, age, 
and length of practice 
18. Speckens et al. 1995 To explore: 
1) To what extent additional 
psychological treatment is 
needed for patients with 
MUS; 
2) To what extent patients 
with MUS are willing to 
accept psychological 
treatment; 
3) How somatizing patients 
who are willing to accept 
psychological treatment 
compare with those who are 
not. 
Quantitative Questionnaires Patients with MUS 





therapy) for MUS 
N/A 1) Patient's belief that it is 
acceptable to receive 
psychological treatment 
for MUS. (Pa) 
19. Van der Feltz- 
Cornelis et al. 
1996 To explore: 
1) The feasibility of a 
psychiatric consultation 
intervention for somatizing 
patients in primary care. 
Quantitative Questionnaires Patients with a 
somatoform disorder 
(n = 46) 
Primary care Psychiatric consultation 
intervention for 
somatizing patients 
N/A 1) Patient's belief that it is 
acceptable to receive 
psychological treatment 
for somatization. (Pa) 
20. Walker et al. 1999 To determine: 
1) Preference for treatment 
among individuals seeking 
help for hypochondriasis. 












N/A 1) Patient's belief that 
psychological treatment is 








treatment. (Pa)  
* I=Intervention; Pr = Professional; Pa = Patient; O=Organizational context; S=Social Context; E = Economic/political context. 
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intervention is easier to implement when it is applicable to multiple 
patient groups; i.e. not only to patients with MUS, but also to patients 
with psychosocial problems due to other (physical) complaints [2]. 
3.3.2. Professional 
Barriers- Most of the barriers at the professional level were related to 
the professional's attitude. So, if professionals feel disengaged from the 
patient's complaints [40] this hinders implementation of MUS -in-
terventions. The professional's beliefs and emotions seem to play a role 
in this; if the professional fears that offering psychological treatment will 
encourage dependency of the patient [14] or that the professional may 
overlook a medical diagnosis [8], this might interfere with successful 
implementation. More in general, if the professional does not feel well 
(emotionally) during consultation, he/she is more likely to use older 
strategies rather than new interventions [14]. Also, the feelings and 
thoughts that patients evoke in professionals are important for the 
implementation success, such as feelings of frustration [16], the idea 
that the MUS-patient has difficulties with changing his/her behavior 
[2,26], or the belief that the patient gets secondary gain from having 
MUS [14]. Obviously, believing that the psychological intervention is 
ineffective or unnecessary for the treatment of MUS [1,21,33] and 
refusing to give psychological treatment [16] are important barriers. 
Other barriers were related to the skills of the professional. For 
instance, if professionals feel incompetent to apply the psychological 
treatment [7,25,40], to refer to psychological treatment [43], or if they 
feel unable to manage MUS [14] or to discuss psychosocial problems 
[34], this prevents successful implementation. 
Finally, some studies describe barriers at the level of the professional- 
patient interaction, such as language barriers [7], including the pro-
fessional's use of psychiatric terminology [25], and different treatment 
expectations between patients and doctors [9]. Patients, for example, 
reported that they were mainly in need of pain relief, while doctors 
seemed to be mainly focused on defining a clear pain management plan 
focused on coping. 
Facilitators- Facilitators on the level of the professional include 
knowledge about MUS, by having followed a course on MUS [1,43], or by 
having been trained in communication and treatment skills [15]. Also, 
an empathic attitude towards MUS-patients [40] and a positive attitude 
towards providing psychological interventions for MUS [21,41] facili-
tate the implementation of MUS-interventions. It also helps when pro-
fessionals feel responsible for the implementation [8,21], or if they 
believe that the intervention is effective for the treatment of MUS [43]. 
3.3.3. Patient 
Barriers- If patients (or their parents in case of children and adoles-
cents) stick to finding a somatic cause for the symptoms, this hampers the 
implementation of MUS-interventions, both according to professionals 
and patients/parents themselves [14,15,26]. Patient-professional 
(communication) barriers have been associated with implementation 
difficulties, such as problems with the patient's language/cultural 
background [25], the patients' simplification of the problems [34], or 
patients' belief that general practitioners (GPs) are unable to or have too 
little time to treat MUS [34]. In general, the previously described dif-
ferences in treatment expectations between patients and professionals 
regarding the outcome of treatment for MUS might hamper the imple-
mentation of MUS-interventions [9]. Lastly, if patients visit multiple 
general practitioners within one practice [14], this is unhelpful for 
implementing interventions for MUS in primary care as continuity of 
care is important when treating MUS. 
Facilitators- On the other hand, if patients believe that the interven-
tion can help with dealing with MUS, and believe that it is acceptable to 
receive psychological treatment for MUS [10,26,44,46,47], this is 
helpful for the successful implementation of MUS-interventions. 
3.3.4. Organizational context 
Barriers- The most frequently mentioned barrier at the level of 
organization is a lack of time for treating patients with MUS and 
implementing MUS-interventions [2,14,15]. Also, the absence of a 
structured protocol or procedure for the specific treatment of MUS in 
secondary care [15] seems unhelpful. Another barrier is the lack of su-
pervision when using or applying the treatment [14]. 
Facilitators- In line with this, it appears that if professionals have the 
ability to take e.g. refreshment courses or peer coaching sessions regarding 
the use of the intervention [7,10], this is helpful for the implementation 
of the MUS-intervention. Moreover, a shared management framework or a 
joint (interdisciplinary) approach towards the treatment of MUS 
[8,10,15,16,26] might facilitate the implementation of MUS- 
interventions in clinical practice. Also, appointing an implementation 
lead within the organization [15] or giving financial rewards when 
using the intervention [14] are possible facilitators. 
3.3.5. Social context 
Barriers- At the level of the social context, the stigma on psychiatric 
classifications (including somatoform disorders) and receiving psycho-
logical healthcare for MUS was considered an important barrier for the 
implementation of MUS-interventions [26], especially if patients were 
from minority ethnic cultures [25]. 
Facilitators- No facilitators were reported on the social context level. 
3.3.6. Economic and political context 
Barriers- According to the research of Dowrick et al. [14], the 
medical-political context is an important barrier as well. This study 
explains how GPs feel inclined to continue looking for a medical diag-
nosis, since missing a somatic diagnosis in the worst-case scenario may 
have a negative impact on their career, even if good psychological 
treatments are available [14]. 
Facilitators- No facilitators were reported on the level of the economic 
context. 
4. Discussion 
4.1. Main findings 
Previous studies have shown that the implementation of evidence- 
based interventions is a process that may take many years [11]. How-
ever, interventions for MUS are urgently needed in clinical care to 
improve the patient's quality of life and to reduce healthcare costs [52]. 
Implementation research [17] shows that there is a greater chance of 
successful implementation if implementation strategies are adapted to 
the specific healthcare context. The present study provides guidance on 
which factors should be taken into account when implementing MUS- 
interventions. Fig. 2 provides a practical model for successfully imple-
menting MUS-interventions in clinical practice based on the imple-
mentation roadmap of Grol and Wensing [18,49]. 
As shown, some barriers are difficult to tackle. First, many studies 
have demonstrated communication problems between professionals and 
MUS-patients (e.g. [37]). Evidence-based interventions have been 
developed to tackle these communication problems [20], but these in-
terventions are also difficult to implement in clinical practice. The same 
applies to the professional's attitude with regard to MUS. Many studies 
have demonstrated the negative attitude towards patients with MUS (e. 
g. [43]), which is problematic, especially since these attitudes seem to be 
present early in the career [42,51]. Negative attitudes towards patients 
with MUS not only present as a barrier to diagnosing MUS [27], but once 
diagnosed, such attitudes also impede the implementation of in-
terventions for patients with MUS. 
Second, the negative feelings that patients evoke in professionals are 
well described in MUS-literature (e.g. [45]). Maintaining a good patient- 
doctor relationship is essential in the treatment of MUS, but this can only 
be achieved if the professional is well trained and empathic. This leaves 
the patient with MUS and the professional in a vicious circle, in which 
interventions are needed to tackle the symptoms, but the professional's 
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emotions are hindering successful implementation of those in-
terventions. A recent study additionally showed that the fear of over-
looking a somatic disease, as well as patients' requests for symptom 
relief, are important barriers for professionals in both diagnosing and 
initiating treatment for persistent somatic complaints [22]. 
4.2. Comparison with barriers to diagnosis of MUS 
Murray et al. [27] previously examined barriers to diagnosing MUS 
and somatoform symptoms in a systematic review of literature. In 
particular, barriers at the patient and professional level seem to overlap 
considerably with our current results, such as the negative attitude of 
professionals to work with MUS-patients and interaction problems be-
tween professionals and MUS-patients. The similarities in barriers are 
especially interesting since the overlap between the papers described by 
Murray et al. and those extracted for the current review is minimal (4/ 
20). Attitude and interaction problems thus seem to hinder both 
appropriate diagnosis and implementation of interventions for MUS. 
When implementing MUS-interventions, however, e.g. the user- 
friendliness of the intervention as well as offering supervision when 
using the intervention seem important for improving implementation 
success. Please see supplementary file D for a complete comparison of 
barriers and facilitators. 
4.3. Strengths and limitations of the current review 
As far as we know, this is the first systematic literature review that 
describes knowledge on barriers and facilitators to the implementation 
of interventions for MUS. Strengths of the current study include our 
systematic way of working conform the PRISMA guidelines and the 
framework of Grol and Wensing [18,49]. Because we did not exclude 
papers based on study design, we were able to extract a wide range of 
barriers and facilitators. It is noteworthy that the studies with a quali-
tative approach provided especially rich information on barriers and 
facilitators in implementation (see supplementary file C). Also, we only 
selected those studies that directly linked MUS-interventions to imple-
mentation barriers and facilitators. 
However, there is also a downside to this. By selecting strictly, we 
may have overlooked factors that are also relevant to the implementa-
tion process. We did not select any (cost-)effectiveness studies, and 
therefore the role of scientific evidence for (cost-)effectiveness in 
implementation success is only briefly discussed in our current study. 
Due to the often brief descriptions of the interventions in the included 
papers and the low number of included papers, it was not possible to 
make a comparison between barriers and facilitators of different types of 
interventions. In terms of methodology, the included quantitative sci-
entific studies showed limited methodological quality (i.e. no appro-
priate measurements, groups were not comparable, data sufficiently 
completed), with possible publication bias as a result. This could imply 
that only papers with strong positive or negative results are published, 
which means that the less pronounced factors influencing implementa-
tion are not addressed in this review. Also, the low methodological 
quality creates uncertainty about the significance of the current results. 
In general, barriers from qualitative studies should be validated in 
quantitative studies, while qualitative studies can elaborate on the 
mentioned barriers in quantitative studies. In general, barriers and fa-
cilitators might differ between countries, e.g. due to differences in the 
healthcare systems. 
4.4. Implications for clinical care and future research 
We believe that providing specific guidance in implementing MUS- 
interventions is of great importance, as clinicians often have limited 
training in implementing interventions and as implementation success is 
unfortunately limited in clinical practice. Also, clinicians have little time 
to consult key studies separately, which argues for a robust synthesis of 
findings. As the methodological quality of the included papers seems 
quite low, there is a need for high-quality studies about the imple-
mentation of MUS-interventions. From this perspective, the application 
of so-called effectiveness-implementation hybrid designs seems 
Fig. 2. Roadmap (based on Grol & Wensing, 2004) for the successful implementation of MUS-interventions in clinical practice.  
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promising [12] as they can simultaneously provide data on effectiveness 
of the interventions alongside evaluation of implementation factors. 
Furthermore, it would be interesting to use this review as a stepping 
stone towards drawing up a comprehensive implementation model for 
MUS-interventions, by merging all knowledge of separate studies on the 
presented barriers/facilitators and knowledge on (cost)effectiveness of 
MUS-treatments into one model for the implementation of MUS- 
interventions. An important finding of this review is that the role of 
social context and economic/political context has hardly been 
researched, which is in accordance to the findings of Nilsen and Bern-
hardsson [29]; developing a greater awareness of these contextual fac-
tors and how they impact on implementation efforts, might contribute to 
a better design of future interventions to be implemented for MUS. In- 
depth research on how the different factors can impede or promote 
implementation and how these factors might change over time, can help 
to better understand the difficult process of implementing interventions 
for MUS in primary and secondary care. 
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